CMR Surgical Secures $200M to Launch Versius Robot in U.S. Market

Cambridge, UK, April 2, 2025 (yahoo finance) -- CMR Surgical closed a $200 million+ funding round to support the global commercialization of its Versius robotic surgery system, with a strategic focus on the U.S. market. The funding follows FDA de novo authorization for Versius in gallbladder removal, setting the stage for broader adoption across American hospitals. CMR, already the second most-used soft tissue robot globally, aims to scale its market presence and accelerate innovation in surgical robotics.

Read full article here.